Global API Sourcing Trends: Why Quality Antibiotics Matter in 2025
Quality antibiotic APIs are critical to combat antimicrobial resistance (AMR). Global buyers prioritize GMP-compliant suppliers (notably Chinese exporters) for resilient sourcing amid regulatory and ESG pressures in 2025.
August 22, 2025
by Saher Haider
The Race to Reinvent Antibiotics: Why Innovation and Access Must Go Hand in Hand
Register to Download PPT and View Why Innovation and Access Must Go Hand in Hand
April 9, 2025
by Neeta Ratanghayra
The ongoing AMR challenge
The development of antimicrobial agents has saved many lives worldwide since the discovery of penicillin in 1928.
May 6, 2024
by Suzanne Elvidge
An estimated 1.2 million people died in 2019 from antibiotic-resistant bacterial infections
More than 1.2 million people - and potentially millions more - died in 2019 as a direct result of antibiotic-resistant bacterial infections, according to the most comprehensive estimate to date of the global impact of antimicrobial resistance (AMR).
January 24, 2022
by Pharmaceutical-Technology
The Lancet warns of 'overlooked pandemic of antimicrobial resistance' in new study
The medical journal highlights antimicrobial resistance (AMR) to be a 'leading cause of death around the world'.
January 21, 2022
by CPhIonline
White paper calls for action on AMR
A group of researchers led by Professor Nirmal Kumar Ganguly, Former Director-General, Indian Council of Medical Research (ICMR), have come out with a white paper on AMR, as it threatens to become the next big public health crisis in India and ...
July 30, 2021
by expresspharma
EU to support novel antibiotics with €20 million funding
BioVersys will receive €20 million in funding to support its development of new treatments for antimicrobial resistant infections.
April 15, 2021
by europeanpharmaceuticalreview
BioVersys Gets EIB Funds to Address Antimicrobial Resistance
The European Investment Bank (EIB) and BioVersys AG, a clinical-stage pharmaceutical company developing treatments for multidrug-resistant bacterial infections, signed a €20 million venture debt transaction.
April 15, 2021
by contractpharma
Cipla Therapeutics and SIGA Technologies enter into strategic partnership
The partnership is to support innovation and provide access to novel antibacterial drugs against biothreats.
March 24, 2021
by expresspharma
INEOS, Oxford University to set up institute for antimicrobial research
INEOS donates £100 million to Oxford Univerity to set up the new institute to fight antimicrobial resistance.
January 20, 2021
by expresspharma
Effective effluent management: Key to tackle AMR
As the world adjusts to the post-COVID-19 reality, it is time to reflect and reset. It cannot be ‘business as usual’ in the struggle to survive.
December 29, 2020
by expresspharma
Novel antibiotic Recarbrio has launched in the UK
MSD’s novel antibiotic treatment Recarbrio has launched in the UK as concerns grow over the rise of antimicrobial resistance (AMR) globally.
November 20, 2020
by pharmatimes